Stanley Druckenmiller Continues Accumulating Shares in Revolution Medicines

Billionaire investor Stanley Druckenmiller has been steadily increasing his position in biotech firm Revolution Medicines, prompting questions about whether he anticipates breakthrough developments ahead of Wall Street consensus.